"At AOA we are committed to providing personalized Rheumatology treatments & infusions in a friendly and relaxed setting. Our experienced team of doctors and professionals treat patients with compassion and are committed to making your treatment options as effective and comfortable as possible. The AOA team will do the pre-authorization for your prescribed service or medications, and we can provide any necessary treatment once approved. We strive to keep wait times to a minimum and offer a comfortable setting for your treatment. We have flexible hours including evenings, and we offer a comprehensive range of treatment options including infusion therapy. Our qualified doctors and staff want to make your AOA experience the best it can be."

During the past decade, Arthritis and Osteoporosis Associates conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 12 clinical trials were completed, i.e. on average, 92.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arthritis and Osteoporosis Associates" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "R-Pharm International, LLC" with 3 trials sponsored, "Pfizer" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arthritis and Osteoporosis Associates" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Mene Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Arthritis and Osteoporosis Associates" are "Rheumatoid Arthritis" (13 trials), "Acute Gout" (1 trials), "Arthritis" (1 trials), "Arthritis, Psoriatic" (1 trials) and "Autoimmune Diseases" (1 trials). Many other conditions were trialed in "Arthritis and Osteoporosis Associates" in a lesser frequency.

Most popular intervention types in "Arthritis and Osteoporosis Associates" are "Drug" (16 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Methotrexate" (5 trials), "Abatacept" (2 trials), "Adalimumab" (2 trials) and "Baricitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arthritis and Osteoporosis Associates" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Arthritis and Osteoporosis Associates". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Arthritis and Osteoporosis Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Arthritis and Osteoporosis Associates, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".